Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Beach

Showing results (231-240 of 653) with videos related to

Pageof 66
Sort By:
Molecular Neurobiology|March 26, 2018
Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's DiseaseJunxiang Yin, Pengcheng Han, Melissa Song, et al.
NPJ Parkinson'S Disease|April 5, 2025
Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortL M Chahine, M C Brumm, A R Nair, et al.
Analytical Chemistry|October 3, 2025
Comprehensive and Site-Specific Characterization of Protein N-Glycosylation in AD Samples Reveals Its Potential Roles in Protein Aggregation and Synaptic DysfunctionXing Xu, Haiyan Tan, Kejun Yin, et al.
Acta Neuropathologica|May 12, 2021
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathiesNikhil Dave, Austin S Vural, Ignazio S Piras, et al.
Alzheimer Disease and Associated Disorders|January 13, 2016
A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative DiseasesBrittany N Dugger, Michael Malek-Ahmadi, Sarah E Monsell, et al.
Dementia and Geriatric Cognitive Disorders|May 15, 2001
Correlation of the expression level of C1q mRNA and the number of C1q-positive plaques in the Alzheimer Disease temporal cortex. analysis of C1q mrna and its protein using adjacent or nearby sectionsI Tooyama, H Sato, O Yasuhara, et al.
Journal of Neurochemistry|February 20, 2009
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologiesPaul W Thompson, Liang Ye, Jennifer L Morgenstern, et al.
Dementia and Geriatric Cognitive Disorders|August 28, 2025
Apolipoprotein E, Executive Function, and Falls Across Cognitive Status: A Cross-Sectional StudyFerdinand Delgado, Fang Yu, Daniel S Peterson, et al.
Frontiers in Neuroscience|May 17, 2021
Cell-Type Specific Changes in DNA Methylation of <i>SNCA</i> Intron 1 in Synucleinopathy BrainsJeffrey Gu, Julio Barrera, Young Yun, et al.
Neuroscience Letters|May 3, 2014
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsThomas G Beach, Jeremiah Carew, Geidy Serrano, et al.
Pageof 66

Showing results (231-240 of 653) with videos related to

Sort By:
Pageof 66
Molecular Neurobiology|March 26, 2018
Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's DiseaseJunxiang Yin, Pengcheng Han, Melissa Song, et al.
NPJ Parkinson'S Disease|April 5, 2025
Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortL M Chahine, M C Brumm, A R Nair, et al.
Analytical Chemistry|October 3, 2025
Comprehensive and Site-Specific Characterization of Protein N-Glycosylation in AD Samples Reveals Its Potential Roles in Protein Aggregation and Synaptic DysfunctionXing Xu, Haiyan Tan, Kejun Yin, et al.
Acta Neuropathologica|May 12, 2021
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathiesNikhil Dave, Austin S Vural, Ignazio S Piras, et al.
Alzheimer Disease and Associated Disorders|January 13, 2016
A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative DiseasesBrittany N Dugger, Michael Malek-Ahmadi, Sarah E Monsell, et al.
Dementia and Geriatric Cognitive Disorders|May 15, 2001
Correlation of the expression level of C1q mRNA and the number of C1q-positive plaques in the Alzheimer Disease temporal cortex. analysis of C1q mrna and its protein using adjacent or nearby sectionsI Tooyama, H Sato, O Yasuhara, et al.
Journal of Neurochemistry|February 20, 2009
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologiesPaul W Thompson, Liang Ye, Jennifer L Morgenstern, et al.
Dementia and Geriatric Cognitive Disorders|August 28, 2025
Apolipoprotein E, Executive Function, and Falls Across Cognitive Status: A Cross-Sectional StudyFerdinand Delgado, Fang Yu, Daniel S Peterson, et al.
Frontiers in Neuroscience|May 17, 2021
Cell-Type Specific Changes in DNA Methylation of <i>SNCA</i> Intron 1 in Synucleinopathy BrainsJeffrey Gu, Julio Barrera, Young Yun, et al.
Neuroscience Letters|May 3, 2014
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsThomas G Beach, Jeremiah Carew, Geidy Serrano, et al.
Pageof 66